---
title: "ALT: Advanced late-stage liver disease trials, improved net loss per share, and raised $225M in new capital"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295659187.md"
description: "Initiated a global Phase 3 MASH trial and reported positive Phase 2 AUD results, while maintaining a strong liquidity position with $519 million in cash and investments. Net loss per share improved year-over-year, and a $225 million public offering was completed.Original document: Altimmune, Inc. [ALT] SEC 8-K Current Report — Aug. 12 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-12T11:40:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295659187.md)
  - [en](https://longbridge.com/en/news/295659187.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295659187.md)
generator: "portal-rs"
---

# ALT: Advanced late-stage liver disease trials, improved net loss per share, and raised $225M in new capital

Initiated a global Phase 3 MASH trial and reported positive Phase 2 AUD results, while maintaining a strong liquidity position with $519 million in cash and investments. Net loss per share improved year-over-year, and a $225 million public offering was completed.

Original document: Altimmune, Inc. \[ALT\] SEC 8-K Current Report — Aug. 12 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ALT.US](https://longbridge.com/en/quote/ALT.US.md)

## Related News & Research

- [Altimmune CEO Jerome Benedict Durso acquires USD 44,250 in common shares](https://longbridge.com/en/news/295838846.md)
- [ALT: Pemvidutide met key efficacy endpoints in AUD, reducing heavy drinking and increasing abstinence](https://longbridge.com/en/news/294057380.md)
- [Filevine launches 90-day free trial for LOIS legal AI system](https://longbridge.com/en/news/296383497.md)
- [AI Has More Winners Than Ever – Here’s the Catch](https://longbridge.com/en/news/296384763.md)
- [Workday Introduces AI Research Team Dedicated to Advancing Reliable, Trustworthy, and Efficient Enterprise AI | WDAY Stock News](https://longbridge.com/en/news/296379259.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**